Fiduciary Trust’s Passage Bio PASG Stock Holding History

Fiduciary Trust’s Portfolio PASG Stock Details PASG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$52.5K	Hold	10,750	–	–	﹤0.01%	890
2026 Q1	$84.4K	Hold	10,750	–	–	﹤0.01%	862
2025 Q4	$127K	Hold	10,750	–	–	﹤0.01%	852
2025 Q3	$86.3K	Hold	10,750	–	–	﹤0.01%	843
2025 Q2	$86.1K	Hold	10,750	–	–	﹤0.01%	821
2025 Q1	$75.9K	Hold	10,750	–	–	﹤0.01%	809
2024 Q4	$122K	Hold	10,750	–	–	﹤0.01%	680
2024 Q3	$151K	Hold	10,750	–	–	﹤0.01%	638
2024 Q2	$171K	Hold	10,750	–	–	﹤0.01%	612
2024 Q1	$290K	Buy	10,750 +5,000	+87%	+$120K	﹤0.01%	567
2023 Q4	$116K	Hold	5,750	–	–	﹤0.01%	613
2023 Q3	$75.7K	Hold	5,750	–	–	﹤0.01%	601
2023 Q2	$108K	Hold	5,750	–	–	﹤0.01%	615
2023 Q1	$110K	Buy	5,750 +250	+5%	+$6.78K	﹤0.01%	603
2022 Q4	$152K	Buy	5,500 +5,000	+1,000%	+$126K	﹤0.01%	607
2022 Q3	$13K	Buy	+500	New	+$19.7K	﹤0.01%	608

Other funds holding PASG

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

YCM

Yiheng Capital Management San Francisco, California $291M AUM 19.43% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Verdad Advisers Boston, Massachusetts $104M AUM

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Fiduciary Trust's PASG Position: Q2 2026 in Review

Fiduciary Trust held its Passage Bio (PASG) position steady in Q2 2026 at 10,750 shares worth $52.5K. The position accounts for ﹤0.01% of the portfolio, ranked #890.

Fiduciary Trust first reported a position in PASG in Q3 2022 and has held it in 16 quarters since. The position peaked at $290K in Q1 2024. 29 funds tracked by Wall St. Rank hold PASG as of Q2 2026.

Fiduciary Trust held 10,750 shares of Passage Bio worth $52.5K as of Q2 2026.
Fiduciary Trust left its Passage Bio share count unchanged in Q2 2026.
Passage Bio made up ﹤0.01% of Fiduciary Trust's portfolio in Q2 2026, its #890 holding.
Fiduciary Trust first reported a position in Passage Bio in Q3 2022 and has held it in 16 quarters since.
Fiduciary Trust's Passage Bio position peaked at $290K in Q1 2024.
29 funds tracked by Wall St. Rank held Passage Bio as of Q2 2026.

Based on Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.